Revvity (RVTY) Stock Forecast & Price Target

$119.74 -0.61 (-0.51%)

(As of 11/13/2024 ET)

Revvity - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 17 Analyst Ratings

Sell
0

Hold
7

Buy
10

Based on 17 Wall Street analysts who have issued ratings for Revvity in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 17 analysts, 7 have given a hold rating, 9 have given a buy rating, and 1 has given a strong buy rating for RVTY.

Consensus Price Target

$132.07
10.29% Upside

According to the 17 analysts' twelve-month price targets for Revvity, the average price target is $132.07. The highest price target for RVTY is $146.00, while the lowest price target for RVTY is $110.00. The average price target represents a forecasted upside of 10.29% from the current price of $119.74.

RVTY Analyst Ratings Over Time

Type	Current Forecast 11/14/23 to 11/13/24	1 Month Ago 10/15/23 to 10/14/24	3 Months Ago 8/16/23 to 8/15/24	1 Year Ago 11/14/22 to 11/14/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	9 Buy rating(s)	8 Buy rating(s)	9 Buy rating(s)	5 Buy rating(s)
Hold	7 Hold rating(s)	8 Hold rating(s)	8 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$132.07	$125.53	$123.81	$118.71
Forecasted Upside	10.29% Upside	2.13% Upside	3.13% Upside	35.19% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

RVTY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

RVTY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Revvity Stock vs. The Competition

Type	Revvity	Medical Companies	S&P 500
Consensus Rating Score	2.65	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Hold
Predicted Upside	10.54% Upside	26,029.68% Upside	7.95% Upside
News Sentiment Rating	Positive News See Recent RVTY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/5/2024	TD Cowen 4 of 5 stars		Boost Target	Buy ➝ Buy	$141.00 ➝ $144.00	+14.86%
11/5/2024	Raymond James 4 of 5 stars		Boost Target	Outperform ➝ Outperform	$144.00 ➝ $146.00	+16.59%
11/5/2024	Sanford C. Bernstein 3 of 5 stars		Lower Target	Outperform ➝ Outperform	$150.00 ➝ $145.00	+15.80%
11/5/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$136.00 ➝ $138.00	+10.56%
10/17/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$130.00 ➝ $135.00	+12.44%
10/15/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Sergott Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$125.00 ➝ $140.00	+13.90%
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover
8/27/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Couillard Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Equal Weight	$130.00	+6.17%
7/30/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$135.00 ➝ $145.00	+17.92%
7/30/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$105.00 ➝ $120.00	-4.45%
7/30/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$118.00 ➝ $127.00	+1.12%
7/29/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$115.00 ➝ $125.00	-0.47%
7/8/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Souda Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
2/2/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$95.00 ➝ $110.00	+4.35%
2/2/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$110.00 ➝ $126.00	+17.75%
1/16/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral	$105.00 ➝ $125.00	+12.82%
1/4/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	In-Line ➝ Outperform	$88.00 ➝ $125.00	+19.02%
12/13/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Peer Perform
10/31/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$120.00 ➝ $105.00	+27.07%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 10:05 PM ET.

RVTY Forecast - Frequently Asked Questions

: According to the research reports of 17 Wall Street equities research analysts, the average twelve-month stock price forecast for Revvity is $132.07, with a high forecast of $146.00 and a low forecast of $110.00.
: 17 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Revvity in the last twelve months. There are currently 7 hold ratings, 9 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RVTY shares.
: According to analysts, Revvity's stock has a predicted upside of 10.29% based on their 12-month stock forecasts.
: Over the previous 90 days, Revvity's stock had 1 upgrade by analysts.
: Revvity has been rated by research analysts at Barclays, Leerink Partners, Raymond James, Robert W. Baird, Sanford C. Bernstein, TD Cowen, and Wells Fargo & Company in the past 90 days.
: Analysts like Revvity less than other "medical" companies. The consensus rating score for Revvity is 2.65 while the average consensus rating score for "medical" companies is 2.80. Learn more on how RVTY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Trump’s Back, but DC’s Coming for Your Money! (Ad)

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

This page (NYSE:RVTY) was last updated on 11/13/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Revvity (RVTY) Stock Forecast & Price Target